AN2 Therapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2017-01-01
- Employees
- 41
- Market Cap
- $34.9M
- Introduction
AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo...
Spero's stock slides after antibiotic flops in Phase II trial
Spero Therapeutics halted development of antibiotic SPR720 after Phase IIa trial failure in NTM-PD patients, leading to 39% staff layoffs and a 17% stock drop. The company plans to focus on tebipenem HBr and SPR206, with tebipenem HBr out-licensed to GSK.
Related Clinical Trials:
© Copyright 2024. All Rights Reserved by MedPath